A systematic MEDLINE analysis of therapeutic approaches in ankylosing spondylitis. [electronic resource]
- Rheumatology international Aug 2009
- 1123-35 p. digital
Publication Type: Journal Article; Review
1437-160X
10.1007/s00296-009-0973-9 doi
Adalimumab Anti-Inflammatory Agents--therapeutic use Anti-Inflammatory Agents, Non-Steroidal--therapeutic use Antibodies, Monoclonal--therapeutic use Antibodies, Monoclonal, Humanized Diphosphonates--therapeutic use Etanercept Humans Immunoglobulin G--therapeutic use Immunosuppressive Agents--therapeutic use Infliximab Interleukin 1 Receptor Antagonist Protein--therapeutic use Isoxazoles--therapeutic use Leflunomide Meta-Analysis as Topic Methotrexate--therapeutic use Multicenter Studies as Topic Pamidronate Randomized Controlled Trials as Topic Receptors, Interleukin-1--antagonists & inhibitors Receptors, Tumor Necrosis Factor--therapeutic use Spondylitis, Ankylosing--drug therapy Steroids--therapeutic use Sulfasalazine--therapeutic use Tumor Necrosis Factor-alpha--antagonists & inhibitors